('SBNO2', 0.00047417203113702435)
('AMT', 0.0004737063127599965)
('hydroxydaunorubicin', 0.0004736781872263261)
('H1-10', 0.0004736689803949764)
('ADPGK', 0.0004736483693251799)
('SOX13', 0.00047348041169040537)
('autoimmune_lymphoproliferative_syndrome', 0.0004734176917115028)
('Neratinib', 0.0004732921470938014)
('gastric_acid_secretion', 0.00047283522807454597)
('HNRNPU', 0.0004728018584053716)
('terminal_loop', 0.0004726899940176116)
('AZU1', 0.00047231482042140767)
('Saracatinib', 0.00047225169755924607)
('SLC6A6', 0.00047206510299690487)
('GRM1', 0.0004720348254490845)
('polyradiculoneuropathy', 0.00047193449917421474)
('UPF1', 0.000471846512497843)
('Magnesium_sulfate', 0.0004718023250806719)
('peritoneal_mesothelioma', 0.00047175870484097223)
('GMPS', 0.0004715092614851506)
('ZIC4', 0.0004710678683093567)
('umbilical_artery', 0.0004710340107001072)
('G1_to_G0_transition', 0.0004709383951362645)
('goserelin', 0.00047085298850496935)
('ovarian_cystadenoma', 0.00047077511926127766)
('IFIT3', 0.0004706801165970889)
('OPN4', 0.00047059526538007255)
('early_endosome', 0.0004700560315126132)
('NS-398', 0.0004694697436854349)
('OLIG2', 0.00046946592481206397)
('ANKRD11', 0.0004694348610921274)
('L-PAM', 0.00046928153588109443)
('cell_migration', 0.0004689564922444995)
('amygdala', 0.0004687852678696329)
('PRDM10', 0.00046869336103104686)
('dermatopathia_pigmentosa_reticularis', 0.00046834539570790823)
('NSL1', 0.0004681423489041068)
('MTF1', 0.00046805134229713447)
('SHMT2', 0.00046804943048945637)
('FOSB', 0.0004679417340902989)
('HCCLM-3_cell', 0.0004679080733179801)
('PDXK', 0.0004674203835285802)
('protein-losing_enteropathy', 0.00046721457459106676)
('mesenchymal_stem_cell_migration', 0.00046700536176862525)
('peliosis_hepatis', 0.00046694988644847336)
('colon_transversum', 0.00046687626625113645)
('PCDH18', 0.00046678580751496017)
('syncytiotrophoblast', 0.0004667673221603295)
('FTA', 0.000466671815229523)
('amlodipine', 0.00046649732785288505)
('AGL', 0.00046642115988720017)
('HK-2_cell', 0.00046627268380006746)
('BCCIP', 0.000466225531467443)
('enhanceosome', 0.0004661655644817018)
('HOXA13', 0.00046606427220408195)
('chromatin_silencing', 0.00046599142171386204)
('MAPK13', 0.0004659213633629963)
('Praziquantel', 0.00046557647637743727)
('deferasirox', 0.0004653290918941384)
('FUT6', 0.000465210796871514)
('viral_latency', 0.00046517883646213226)
('GH3_cell', 0.0004649404634604117)
('neuroblast', 0.0004649003325195159)
('MTHFD1', 0.00046487409004608874)
('BDNF-AS', 0.00046483651589437154)
('LNCARSR', 0.0004648219477056984)
('IL17RD', 0.00046470887436975275)
('RAP1B', 0.00046433543172725764)
('Catumaxomab', 0.00046396282182393773)
('phosphorylase_kinase_activity', 0.00046396072430966316)
('PIK3R5', 0.0004638448717812938)
('GOLM1', 0.0004638174884227894)
('protein_kinase_A_(PKA)_signaling_pathway', 0.0004637040191008446)
('cerebral_malaria', 0.0004636060919732445)
('TUFT1', 0.00046341297032612236)
('RHOG', 0.00046334743063969455)
('RPL35', 0.0004630249395005046)
('MIR487B', 0.0004630244676724295)
('immunoglobulin_alpha_deficiency', 0.00046282465296286035)
('SLCO1A2', 0.0004622683624516287)
('Tinzaparin', 0.0004619250884880386)
('MAP2K1', 0.00046187048551817533)
('MDH2', 0.00046160081280569195)
('vildagliptin', 0.000461586905704882)
('LAMC1', 0.0004614867899458217)
('EMILIN2', 0.0004614189963235082)
('aortic_arch', 0.0004613614135480555)
('myofibroblast_differentiation', 0.0004611157069515284)
('AHSG', 0.0004610930025626964)
('PTPN12', 0.00046088375278388344)
('hyaline_fibromatosis_syndrome', 0.00046083821957494116)
('congenital_vertical_talus', 0.0004606841288296105)
('EMC6', 0.0004605919571195127)
('tapentadol', 0.00046025694150685526)
('FAM107B', 0.0004596514290654246)
('LINC01638', 0.0004596352945718598)
('INHBB', 0.00045962728270927813)
('PTCSC1', 0.00045950017518915686)
('gliosarcoma', 0.0004594608714897517)
('mitogen-activated_protein_kinase_binding', 0.0004594245808235941)
('clemastine', 0.0004594107383988184)
('acute_pyelonephritis', 0.0004594079657665233)
('mitochondrial_inner_membrane_peptidase_complex', 0.00045935213804945495)
('FBXO22', 0.00045932193994214246)
('papilledema', 0.0004591639252554473)
('MED18', 0.00045900400067002176)
('calcium_transmembrane_transporter_activity__phosphorylative_mechanism', 0.00045888101469850366)
('colon_sigmoideum', 0.0004585918092769832)
('Lewis_lung_carcinoma_cell_line', 0.0004585244574255131)
('ovarian_clear_cell_carcinoma', 0.0004582394967068359)
('ASB16-AS1', 0.0004582104871799897)
